In the News

UVA emergency room doctors are highlighting the virus’s underappreciated risks and potential drug interactions.

UVA Heath researcher Dr. William A. Petri, who is working on a vaccine for COVID-19, takes heart from history.

UVA found that fluvoxamine may prevent dangerous immune system overreactions, a major threat to COVID-19 patients.

UVA has pioneered an innovative new use for telemedicine in the battle against COVID-19, adapting it to improve patient care, conserve PPE and prevent infections.

The University research community is putting the novel coronavirus and its effects under the microscope.

The online registry is an open to all Virginia residents, healthy or sick, and seeks to provide a fuller picture of COVID-19 in the commonwealth.

New approaches under study at UVA could revolutionize treatment for conditions from Alzheimer’s to epilepsy to brain tumors – and even help repair the devastating damage caused by stroke.

Jim Galloway and Timothy Wilson last week became the fourth and fifth UVA faculty members elected to the National Academy of Sciences for their pathbreaking research.